Crypto exchange FTX launches $2bn venture fund
Alara Jordan •
TCDA
TCDA
Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). It has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.
White Paper Declaration
White Paper Declaration
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in
TCDA price history
| Date | Close | Change | Change(%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 18, 2022 | 8.71 | 0.08 | 0.93% | 8.63 | 8.86 | 8.59 |
| Jan 14, 2022 | 8.82 | 0.21 | 2.44% | 8.61 | 8.88 | 8.54 |
| Jan 13, 2022 | 8.79 | 0.02 | 0.23% | 8.77 | 9.01 | 8.56 |
| Jan 12, 2022 | 8.86 | -0.40 | -4.32% | 9.26 | 9.35 | 8.77 |
| Jan 11, 2022 | 9.32 | 0.34 | 3.79% | 8.98 | 9.76 | 8.98 |
| Jan 10, 2022 | 9.17 | 0.36 | 4.09% | 8.81 | 9.28 | 8.71 |
| Jan 7, 2022 | 9.00 | 0.15 | 1.69% | 8.85 | 9.26 | 8.76 |
| Jan 6, 2022 | 8.98 | 0.16 | 1.81% | 8.82 | 9.21 | 8.69 |
| Jan 5, 2022 | 8.92 | -0.28 | -3.04% | 9.20 | 9.38 | 8.77 |
| Jan 4, 2022 | 9.19 | 0.33 | 3.72% | 8.86 | 9.26 | 8.61 |
| Jan 3, 2022 | 8.78 | -0.74 | -7.77% | 9.52 | 9.85 | 8.42 |
| Dec 31, 2021 | 9.48 | 0.42 | 4.64% | 9.06 | 9.55 | 9.06 |
| Dec 30, 2021 | 9.20 | 0.12 | 1.32% | 9.08 | 9.36 | 9.08 |
| Dec 29, 2021 | 9.30 | 0.50 | 5.68% | 8.80 | 9.48 | 8.74 |
| Dec 28, 2021 | 9.04 | -0.11 | -1.20% | 9.15 | 9.50 | 8.93 |
| Dec 27, 2021 | 9.30 | 0.02 | 0.22% | 9.28 | 9.51 | 9.20 |
| Dec 23, 2021 | 9.12 | 0.22 | 2.47% | 8.90 | 9.25 | 8.90 |
| Dec 22, 2021 | 8.99 | 0.04 | 0.45% | 8.95 | 9.06 | 8.76 |
| Dec 21, 2021 | 8.92 | 0.00 | 0.00% | 8.92 | 9.16 | 8.74 |
| Dec 20, 2021 | 8.82 | 0.55 | 6.65% | 8.27 | 8.88 | 8.21 |